Name: BIOCRYST PHARMACEUTICALS INC (BCRX) Stock
Brand: BIOCRYST PHARMACEUTICALS INC
Rating: 4.5 (3 reviews)

BCRX Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: Chartmill

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) Posts Mixed Q3 2025 Results, Beats on EPS But Misses Revenue

2 days ago - By: Astria Therapeutics, Inc. - Mentions: ATXS

Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

9 days ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

9 days ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Present at Upcoming Investor Conference

10 days ago - By: The Motley Fool

BioCryst (BCRX) Q3 2025 Earnings Call Transcript

11 days ago - By: Benzinga - Mentions: SNAP IONQ CGC BLNK ...

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More

11 days ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update

11 days ago - By: Benzinga - Mentions: ON TIMB GT IRMD ...

Earnings Scheduled For November 3, 2025

17 days ago - By: Brodsky & Smith LLC - Mentions: SOHO HOLX ATXS PCH ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sotherly Hotels Inc. (Nasdaq – SOHO), Hologic, Inc. (Nasdaq – HOLX), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

22 days ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting

24 days ago - By: Brodsky & Smith LLC - Mentions: HOLX TRUE PCH RYN ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hologic, Inc. (Nasdaq – HOLX), TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

25 days ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Report Third Quarter 2025 Financial Results on November 3

a month ago - By: Brodsky & Smith LLC - Mentions: TRUE ATXS PCH SWKH ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), SWK Holdings Corporation (Nasdaq – SWKH)

a month ago - By: Stocktwits - Mentions: ATXS

BioCryst Stock Tumbles On Astria Buyout, But Analysts Stay Bullish — Retail Cheers The Move As Long-Term Play

a month ago - By: Stocktwits - Mentions: ATXS

BioCryst To Acquire Astria Therapeutics In $700M Deal

a month ago - By: Astria Therapeutics, Inc. - Mentions: ATXS

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile

a month ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile

a month ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business

2 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Present at Upcoming Investor Conference

3 months ago - By: Zacks Investment Research

Are Options Traders Betting on a Big Move in BCRX Stock?

3 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Announces Departure of Dr. Helen Thackray

3 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Stocktwits - Mentions: IWMW AVUS

BioCryst Eyes Strengthening Pipeline After Upbeat Q2 Earnings: Retail Thinks Fair Valuation For Stock Is Double The Current Level

3 months ago - By: The Motley Fool

BioCryst (BCRX) Q2 Revenue Jumps 50%

3 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December

4 months ago - By: Zacks Investment Research - Mentions: ESPR

Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for

4 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Report Second Quarter 2025 Financial Results on August 4

4 months ago - By: Yahoo Finance - Mentions: RY RY.CA WVE

BIOCRYST PHARMACEUTICALS INC (BCRX) Stock News

BCRX Latest News, Press Relases and Analysis

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) Posts Mixed Q3 2025 Results, Beats on EPS But Misses Revenue

Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst to Present at Upcoming Investor Conference

BioCryst (BCRX) Q3 2025 Earnings Call Transcript

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More

BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update

Earnings Scheduled For November 3, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sotherly Hotels Inc. (Nasdaq – SOHO), Hologic, Inc. (Nasdaq – HOLX), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hologic, Inc. (Nasdaq – HOLX), TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

BioCryst to Report Third Quarter 2025 Financial Results on November 3

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), SWK Holdings Corporation (Nasdaq – SWKH)

BioCryst Stock Tumbles On Astria Buyout, But Analysts Stay Bullish — Retail Cheers The Move As Long-Term Play

BioCryst To Acquire Astria Therapeutics In $700M Deal

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst to Present at Upcoming Investor Conference

Are Options Traders Betting on a Big Move in BCRX Stock?

BioCryst Announces Departure of Dr. Helen Thackray

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst Eyes Strengthening Pipeline After Upbeat Q2 Earnings: Retail Thinks Fair Valuation For Stock Is Double The Current Level

BioCryst (BCRX) Q2 Revenue Jumps 50%

BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update

BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December

Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for

BioCryst to Report Second Quarter 2025 Financial Results on August 4

RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13